Pharmarise Holdings, Jun-Aug (1Q) Ordinary Profit Increases by 5.0 times

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Sep 25, 2025 12:00 pm JST Earnings

2796 Pharmarise Holdings Corporation 【J-GAAP】

Earnings Report

Pharmarise Holdings Corporation <2796> [TSE Std] announced its financial results at noon (12:00) on September 25th. The consolidated ordinary profit for the first quarter of the fiscal year ending May 2026 (June to August) surged 5.0 times that of the same period last year, reaching 115 million yen. However, Progress toward the plan for the six months ending November (first half) of 363 million yen was 31.7%, also falling below the five-year average of 57.0%.

In the most recent three-month period, from June to August (1Q), the operating profit margin improved from 0.3% in the same period last year to 0.9%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jun - Aug, 2023	13,471	331	331	123	13.1	47.2	Oct 2, 2023	J-GAAP
Jun - Aug, 2024	15,231	52	23	-131	-11.7	79.3	Sep 25, 2024	J-GAAP
Jun - Aug, 2025	16,753	152	115	-18	-1.6	31.7	Sep 25, 2025	J-GAAP
YoY	+10.0%	+192.3%	+400.0%	+86.3%	+86.1%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jun - Nov, 2024	30,544	100	29	-113	-10.1	0	Dec 25, 2024	J-GAAP
Jun - Nov, 2025 Guidance	33,144	390	363	99	8.6	0	Jun 25, 2025	J-GAAP
YoY	+8.5%	+290.0%	+1,151.7%	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
May, 2024	54,466	916	833	-351	-33.4	20	Jun 28, 2024	J-GAAP
May, 2025	63,508	293	136	-367	-32.5	14	Jun 25, 2025	J-GAAP
May, 2026 Guidance	66,795	1,123	941	266	23.1	14	Jun 25, 2025	J-GAAP
YoY	+5.2%	+283.3%	+591.9%	－	－

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jun - Aug, 2024	15,231	52	23	-131	-11.7	0.3	Sep 25, 2024	J-GAAP
Sep - Nov, 2024	15,313	48	6	18	1.6	0.3	Dec 25, 2024	J-GAAP
Dec - Feb, 2024	16,035	-5	-47	-159	-14.1	0.0	Mar 25, 2025	J-GAAP
Mar - May, 2025	16,929	198	154	-95	-8.4	1.2	Jun 25, 2025	J-GAAP
Jun - Aug, 2025	16,753	152	115	-18	-1.6	0.9	Sep 25, 2025	J-GAAP
YoY	+10.0%	+192.3%	+400.0%	+86.3%	+86.1%